Riskpilot← Back to searchSign inGet full accessCB Diagnostics Holding AB
ABActiveOrg 5567129050Activities of holding companies · NACE 6421Est. 20060 employees
Revenue 2024
SEK 0
EBITDA margin
—
-200% vs 2023
Equity ratio
54.4%
Financial strength
Net profit 2024
SEK -32,5M
+90% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | -200% |
| Net profit | SEK -32,5M | +90% |
| Total assets | SEK 12,1B | +80% |
| Equity | SEK 6,6B | +0% |
| Employees | 0 | — |
Legal name
CB Diagnostics Holding AB
Org number
5567129050
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
13 oktober 2006
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, aktivt verka för en ändamålsenlig samordning och utveckling av den verksamhet som bedrivs i dotterbolag, främst avseende utveckling, tillverkning och marknadsföring av diagnostiska produkter samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 281 300 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 16 200 | −24 | −2 | −2 | −2 | 0 | 0 | −25 787 | −1 | −1 | −3 |
| Depreciation & amort. | — | −0 | −0 | — | — | — | — | — | — | — | — |
| EBIT | 16 200 | −24 | −2 | −2 | −2 | 0 | 0 | −25 787 | −1 | −1 | −3 |
| Net financials | −366 600 | −453 444 | 246 556 | −415 657 | −453 444 | −37 787 | −453 444 | −453 444 | −453 447 | −497 046 | −225 419 |
| Profit before tax | −224 500 | −418 137 | 1 777 055 | −415 659 | −453 445 | −23 754 | −453 446 | −300 704 | −296 992 | −303 579 | 1 |
| Tax | 20 300 | 91 990 | −236 952 | 83 313 | 93 409 | −2 023 | −0 | −0 | −22 560 | −27 898 | −32 540 |
| Net profit | −204 200 | −326 147 | 1 540 103 | −332 346 | −360 036 | −25 777 | −453 446 | −300 704 | −319 552 | −331 477 | −32 539 |
| Item | 2007 | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14 132 300 | 9 638 031 | 11 631 578 | 11 714 889 | 11 808 296 | 11 820 306 | 11 820 304 | 11 973 044 | 11 928 409 | 6 734 118 | 12 130 188 |
| Equity | 696 700 | 233 526 | 1 773 629 | 1 441 283 | 1 081 247 | 1 055 469 | 602 023 | 301 319 | −196 760 | 6 629 800 | 6 597 261 |
| Long-term debt | 12 774 100 | 6 976 061 | 6 976 061 | 6 976 061 | 6 976 061 | 6 976 061 | 6 976 061 | 6 976 061 | 6 976 061 | 0 | 0 |
| Short-term debt | 661 500 | 2 428 444 | 2 881 888 | 3 297 545 | 3 750 989 | 3 788 776 | 4 242 220 | 4 695 664 | 5 149 108 | 104 318 | 5 532 927 |
| Total debt | 13 435 600 | 9 404 505 | 9 857 949 | 10 273 606 | 10 727 050 | 10 764 837 | 11 218 281 | 11 671 725 | 12 125 169 | 104 318 | 5 532 927 |
EBITDA margin
-300000.0%
This company
15.8%
Market median
-1898834% vs market
20072024
Equity ratio
54.4%
This company
38.2%
Market median
+42% vs market
20072024
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20072024
Net profit margin
-3253900000.0%
This company
8.1%
Market median
-40171605038% vs market
20072024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20072024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20072024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-12-01 – 2019-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2007Filed via Bolagsverket / SCB · Period 2006-10-01 – 2007-02-28
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Chief Auditor | Chief Auditor | 2020 | — | — |
HC Authorized Recipient of Service | Authorized Recipient of Service | 2020 | — | — |
VG Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
EE Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Perbio Science Sweden Holdings AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fsii Sweden Holdings ABPerbio Science ABPerbio Science Sweden Holdings AB
CB Diagnostics Holding AB (this company)Board members of CB Diagnostics Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Maria Josefine Jernebring | Chief Auditor | 0 companies |
| Hanna Chainikova | Authorized Recipient of Service | 0 companies |
| Valerio Gaddi | Authorized Recipient of Service | 0 companies |
| Elias Ego | Authorized Recipient of Service | 0 companies |
| Marcel Jacobus van der Meijden | Board of Directors | 0 companies |
| Bram Monster | Board of Directors | 0 companies |
| Anthony Hugh Smith | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |